Screener
Armata Pharmaceuticals
ARMPArmata Pharmaceuticals is a late clinical-stage biotechnology company developing pathogen-specific bacteriophage therapeutics to treat antibiotic-resistant and multidrug-resistant bacterial infections.
$151.33M+41.1%
Earnings
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$450.0K
EPS estimate-$0.57
Competitors
By market cap
By revenue growth
Profile
Armata Pharmaceuticals is a late clinical-stage biotechnology company developing pathogen-specific bacteriophage therapeutics to treat antibiotic-resistant and multidrug-resistant bacterial infections. The company leverages a proprietary platform to engineer high-purity, high-potency phage cocktails that target specific bacteria while preserving the healthy human microbiome.
Competitive position
A leading developer of clinical-stage phage therapeutics with proprietary cGMP manufacturing capabilities and multiple Phase 2 clinical trial completions.
GeographiesUnited States
Customer segmentsCystic fibrosis patients, Non-cystic fibrosis bronchiectasis patients, Hospitalized pneumonia patients, Bacteremia patients
Business modelR&D-based drug development, Biotechnology licensing
SuppliersRaw material suppliers for cGMP manufacturing, Clinical research organizations, Specialized laboratory equipment providers
CustomersInfectious disease specialists, Pulmonologists, Acute care hospitals, Government defense agencies
CountryUnited States of America
Listed1994
Employees75.0
CEODeborah L. Birx
SectorHealthcare
IndustryBiotechnology
Websitearmatapharma.com
FilingsSEC EDGAR
FAQ
- What is Armata Pharmaceuticals's market cap?
- Armata Pharmaceuticals (ARMP) has a market capitalization of $151.3M and trades on AMEX.
- Who are Armata Pharmaceuticals's competitors?
- Armata Pharmaceuticals's key competitors include BiomX Inc., Spero Therapeutics, Inc. Common Stock, Acurx Pharmaceuticals, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Armata Pharmaceuticals partner with?
- Armata Pharmaceuticals's notable partners include Cystic Fibrosis Foundation, Medical Technology Enterprise Consortium, U.S. Department of Defense, and others.
- Where is Armata Pharmaceuticals headquartered?
- Armata Pharmaceuticals is headquartered in United States of America and employs approximately 75 people. It has been publicly traded since 1994.